share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

辉瑞 | 4：持股变动声明-高管 JOHNSON RADY A
美股SEC公告 ·  07/12 13:27
Moomoo AI 已提取核心信息
On July 11, 2024, Rady A Johnson, the Executive Vice President of Pfizer Inc [PFE], was reported to have engaged in a transaction involving the company's stock. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Johnson after the action. The transaction is of interest to investors monitoring insider activity within Pfizer, a leading pharmaceutical company.
On July 11, 2024, Rady A Johnson, the Executive Vice President of Pfizer Inc [PFE], was reported to have engaged in a transaction involving the company's stock. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Johnson after the action. The transaction is of interest to investors monitoring insider activity within Pfizer, a leading pharmaceutical company.
2024年7月11日，辉瑞公司[PFE]执行副总裁拉迪·A·约翰逊被报道参与了一笔涉及公司股票的交易。公告没有透露具体交易细节，如动作类型、股票数量、股票性质、交易价格和股票总价值等。报告没有提供约翰逊行动后持有股数的信息。此次交易对于监控领先的药品公司辉瑞内幕交易的投资者具有可观的兴趣。
2024年7月11日，辉瑞公司[PFE]执行副总裁拉迪·A·约翰逊被报道参与了一笔涉及公司股票的交易。公告没有透露具体交易细节，如动作类型、股票数量、股票性质、交易价格和股票总价值等。报告没有提供约翰逊行动后持有股数的信息。此次交易对于监控领先的药品公司辉瑞内幕交易的投资者具有可观的兴趣。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息